Two activist hedge funds recently entered standstill agreements with Quipt Home Medical Corporation. While not for certain, these agreements, plus other factors, suggest that management and the activists are cooperating, with the company shifting focus from making new acquisitions, to maximizing shareholder value. Whether via sale of the company, or through an operational turnaround, QIPT stock could surge to prices between $4 and $4.75 per share.
Quipt Home Medical Corp. (NASDAQ:QIPT ) Q1 2025 Earnings Conference Call February 11, 2025 10:00 AM ET Company Participants Greg Crawford - Chairman & Chief Executive Officer Hardik Mehta - Chief Financial Officer Conference Call Participants Richard Close - Canaccord Genuity Doug Cooper - Beacon Securities Julian Hung - Stifel Bill Sutherland - The Benchmark Company Operator Thank you for standing by. This is the conference operator.
CINCINNATI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its first quarter fiscal year 2025 financial results and operational highlights. These results pertain to the three months ended December 31, 2024 and are reported in U.S. Dollars.
Reaffirms commitment to enhancing shareholder value and strong corporate governance Reaffirms commitment to enhancing shareholder value and strong corporate governance
CINCINNATI, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal first quarter 2025 financial results on Monday, February 10, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, February 11, 2025, at 10:00 a.m. (ET).
Quipt Home Medical's recurring revenue model and strong gross margins provide stability, despite recent setbacks and a 50% stock drop this year. Operational challenges, including Medicare policy changes and a cyberattack, have impacted revenue and profitability, contributing to the stock's decline. The company has a solid growth plan focused on organic expansion and acquisitions, aiming for 8%-10% growth in FY2025.
Quipt Home Medical Corp. (NASDAQ:QIPT ) Q4 2024 Earnings Conference Call December 17, 2024 10:00 AM ET Company Participants Greg Crawford - Chairman & Chief Executive Officer Hardik Mehta - Chief Financial Officer Conference Call Participants Richard Close - Canaccord Genuity Bill Sutherland - The Benchmark Company Julian Hung - Stifel Doug Cooper - Beacon Securities Operator Thank you for standing by. This is the conference operator.
Quipt Home Medical Corp. (QIPT) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.01. This compares to loss of $0.03 per share a year ago.
Posts Strong Adjusted EBITDA Margin 1 for Fiscal Year 2024 and Returns to Positive Sequential Growth in Fiscal Q4 2024
CINCINNATI, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal fourth quarter and full year 2024 financial results on Monday, December 16, 2024, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, December 17, 2024, at 10:00 a.m. (ET).